Its rivals are also facing similar accusations over their part in the epidemic
In fact, a 2025 study published in JAMA cites steep list prices (over $1000 a month) and spotty insurance coverage as top reasons why most people seeking to lose weight quit taking meds like Ozempic or Vaxenda within a year
People think about dopamine hits as bad or dopamine as bad
However, in this analysis, we observed similar treatment benefits of semaglutide for all primary and confirmatory secondary endpoints across the spectrum of obesity categories
These medications include: Tirzepatide (Zepbound, Mounjaro) Semaglutide (Wegovy, Ozempic, Rybelsus) Liraglutide (Saxenda) Dulaglutide (Trulicity) These medications are part of Calibrates comprehensive Metabolic Reset, which combines GLP-1 treatment with lifestyle coaching, an evidence-based curriculum, and metabolic tracking for sustainable weight loss